Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LA ESPERANZA CLINIC, INC.

NPI: 1265601371 · SAN ANGELO, TX 76903 · Federally Qualified Health Center (FQHC) · NPI assigned 02/22/2008

$2.09M
Total Medicaid Paid
36,582
Total Claims
29,760
Beneficiaries
53
Codes Billed
2019-03
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCASTANEDA, ROSIE (CFO)
NPI Enumeration Date02/22/2008

Related Entities

Other providers sharing the same authorized official: CASTANEDA, ROSIE

ProviderCityStateTotal Paid
LA ESPERANZA CLINIC INC SAN ANGELO TX $1.62M
LA ESPERANZA CLINIC, INC. SAN ANGELO TX $568K
LA ESPERANZA CLINIC, INC. SAN ANGELO TX $13K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 12 $2K
2020 116 $15K
2021 6,031 $338K
2022 4,895 $261K
2023 14,557 $767K
2024 10,971 $710K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
T1015 Clinic visit/encounter, all-inclusive 11,611 9,008 $1.46M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5,762 4,770 $160K
D0999 Unspecified diagnostic procedure, by report 679 645 $115K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 674 606 $70K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 637 594 $65K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 654 582 $61K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,305 1,152 $52K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 458 429 $37K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 266 241 $24K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 664 611 $12K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 188 174 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,596 737 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,036 949 $6K
99384 103 92 $4K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 126 113 $3K
99000 845 759 $3K
G0467 Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit 26 25 $775.00
0001A 12 12 $480.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 2,495 2,204 $329.35
D1110 Prophylaxis - adult 50 50 $316.17
96110 Developmental screening, with scoring and documentation, per standardized instrument 73 73 $269.60
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 54 49 $267.44
90472 Immunization administration, each additional vaccine (list separately) 2,039 1,188 $194.18
81025 102 85 $180.75
D0150 Comprehensive oral evaluation - new or established patient 72 69 $164.00
D0330 Panoramic radiographic image 13 13 $121.40
D0120 Periodic oral evaluation - established patient 28 28 $78.00
86580 38 31 $77.50
92551 1,003 880 $54.32
D0220 Intraoral - periapical first radiographic image 12 12 $53.30
90658 92 91 $48.36
90686 506 478 $0.02
D1120 Prophylaxis - child 229 226 $0.00
99173 844 716 $0.00
90670 268 250 $0.00
90710 96 91 $0.00
90633 133 125 $0.00
90648 135 128 $0.00
90734 178 169 $0.00
91300 34 27 $0.00
90715 116 102 $0.00
90649 15 15 $0.00
90651 253 221 $0.00
D1206 Topical application of fluoride varnish 356 353 $0.00
90688 253 164 $0.00
D0601 212 211 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 68 63 $0.00
90619 40 26 $0.00
90723 78 68 $0.00
D0603 12 12 $0.00
90696 14 14 $0.00
90677 14 14 $0.00
90620 15 15 $0.00